Erasca, Inc. (ERAS)
NASDAQ: ERAS · Real-Time Price · USD
16.25
+0.09 (0.56%)
At close: Sep 15, 2026, 4:00 PM EDT
16.15
-0.10 (-0.62%)
After-hours: Sep 15, 2026, 4:29 PM EDT
Erasca Market Cap
Erasca has a market cap or net worth of $5.68 billion as of September 15, 2026. Its market cap has increased by 1,184.36% in one year.
Market Cap
5.68B
Enterprise Value
5.34B
1-Year Change
1,184.36%
Ranking
Category
Stock Price
$16.25
ChartMarket Cap Chart
Since the IPO on July 16, 2021, Erasca's market cap has increased from $1.86B to $5.68B, an increase of 205.85%. That is a compound annual growth rate of 24.14%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 15, 2026 | 5.68B | 438.52% |
| Dec 31, 2025 | 1.06B | 48.72% |
| Dec 31, 2024 | 709.65M | 121.27% |
| Dec 29, 2023 | 320.72M | -50.41% |
| Dec 30, 2022 | 646.73M | -65.76% |
| Dec 31, 2021 | 1.89B | 1.66% |
| Jul 16, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Mirum Pharmaceuticals | 6.38B |
| Travere Therapeutics | 6.24B |
| Oruka Therapeutics | 6.12B |
| Dianthus Therapeutics | 5.94B |
| Cogent Biosciences | 5.80B |
| Xenon Pharmaceuticals | 5.68B |
| Ligand Pharmaceuticals | 5.67B |
| PTC Therapeutics | 5.51B |